• Achord JL, Gunn CH Jr, Jackson JF 1982 Regional enteritis and HLA concordance in multiple siblings. Dig. Dis. Sci. 27: 330-332.

• Albini E, Marca G, Mellerio G 1982 Further observations on the in vitro metabolism of chenodeoxycholic acid and ursodeoxycholic acid. Arzneimittelforschung 32: 1554-1557.

• Asakura H, Tsuchiya M, Aiso S, Watanabe M, Kobayashi K, Hibi T, Ando K, Takata H, Sekiguchi S 1982 Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis. Gastroenterology 82: 413-418.

• Ayadi S, Ellouze M, Fredj N, Gargouri M, Hamza H 1982 Primary sclerosing cholangitis. Tunis. Med. 60: 270-274.

• Azad Khan AK, Truelove SC, Aronson JK 1982 The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br. J. Clin. Pharmacol. 13: 523-528.

• Azria D, Duval G, Brage D, Deltour D, Valette M 1982 Primary sclerosing cholangitis. External biliary drainage by the transhepatic percutaneous approach. A case report. J. Radiol. 63: 359-362.

• Band PR, Besner JG, Leclaire R, Girard C, Diorio G, Deschamps M, Gélinas M, Larochelle D 1982 Phase I study of 13-cis-retinoic acid toxicity. Cancer Treat. Rep. 66: 1759-1761.

• Bannaski H 1982 For which liver diseases is immunosuppressive therapy indicated? Med. Klin. [Prax.] 77: 66-71, 74.

• Bass NM, Burroughs AK, Scheuer PJ, James DG, Sherlock S 1982 Chronic intrahepatic cholestasis due to sarcoidosis. Gut 23: 417-421. *

• Baur G, Schwalbach G, Tittor W 1982 New aspects of the pathogenesis of primary biliary cirrhosis, a study of 42 patients. Dtsch. Med. Wochenschr. 107: 378-382.

• Bazzoli F, Fromm H, Sarva RP, Sembrat RF, Ceryak S 1982 Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon. Gastroenterology 83: 753-760.

• Bazzoli F, Roda A, Fromm H, Sarva RP, Roda E, Barbara L 1982 Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey. Dig. Dis. Sci. 27: 417-424.

• Berg PA, Klein R, Lindenborn-Fotinos J, Kloppel W 1982 ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet 2: 1423-1426.

• Bernstein RM, Callender ME, Neuberger JM, Hughes GR, Williams R 1982 Anticentromere antibody in primary biliary cirrhosis. Ann. Rheum. Dis. 41: 612-614. *

• Bhan AK, Dienstag JL, Wands JR, Schlossman SF, Reinherz EL 1982 Alterations of T-cell subsets in primary biliary cirrhosis. Clin. Exp. Immunol. 47: 351-358. *

• Bikle DD 1982 The vitamin D endocrine system. Adv. Intern. Med. 27: 45-71.

• Brailski Kh, Chernev K, Pomakov P, Bozhianov V 1982 Percutaneous transhepatic cholangiography with an ultra-fine needle (Chiba) in the diagnosis and differential diagnosis of cholestasis. Vutr. Boles. 21: 29-36.

• Brauman A, Katzir D, Novis B, Eshchar J, Gilboa Y 1982 Primary sclerosing cholangitis. Harefuah. 102: 287-289.

• Bretagne JF, Tassou R, Ramee MP, Grossetti D, Chevrant-Breton J, Gastard J 1982 Fulminant idiopathic ulcerative colitis, primary sclerosing cholangitis and pyoderma gangrenosum. Gastroenterol. Clin. Biol. 6: 448-453.

• Brinch L, Teisberg P, Schrumpf E, Akesson I 1982 The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis. Scand. J. Gastroenterol. 17: 523-527.

• Brunner G, Harke U 1982 Treatment of bleeding oesophageal varices. Results of combined medical and endoscopically selective intravascular sclerotherapy. Dtsch. Med. Wochenschr. 107: 1791-1795.

• Callahan R, Drohan W, Tronick S, Schlom J 1982 Detection and cloning of human DNA sequences related to the mouse mammary tumor virus genome. Proc. Natl. Acad. Sci. U.S.A. 79: 5503-5507. *

• Carroll BA, Oppenheimer DA 1982 Sclerosing cholangitis: sonographic demonstration of bile duct wall thickening. AJR Am. J. Roentgenol. 139: 1016-1018. *

• Chi YB 1982 Surgical treatment of primary sclerosing cholangitis. Zhonghua Wai Ke Za Zhi 20: 223-226.

• Clarke DF, George D, Milsap RL, Pogonowska-Wala E, Owerbach J, Lebenthal E, Jusko WJ 1982 Sulfasalazine metabolite pharmacokinetics in pediatric patients with inflammatory bowel disease: effects of disease activity, acetylator phenotype, and age. Pediatr. Pharmacol. (New York) 2: 323-333.

• Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER 1982 Autoimmune associations in primary biliary cirrhosis. Mayo Clin. Proc. 57: 365-370.

• Cunnigham D, Mills PR, Quigley EM, Patrick RS, Watkinson G, MacKenzie JF, Russell RI 1982 Hepatic granulomas: experience over a 10-year period in the West of Scotland. Q. J. Med. 51: 162-170.

• Czaja AJ, Davis GL 1982 Hepatitis non A, non B. Manifestations and implications of acute and chronic disease. Mayo Clin. Proc. 57: 639-652.

• Danielsson A, Lorentzon R, Larsson SE 1982 Intestinal absorption and 25-hydroxylation of vitamin D in patients with primary biliary cirrhosis. Scand. J. Gastroenterol. 17: 349-355.

• Danielsson A, Lorentzon R, Larsson SE 1982 Normal hepatic vitamin-D metabolism in icteric primary biliary cirrhosis associated with pronounced vitamin-D deficiency symptoms. Hepatogastroenterology 29: 6-8.

• Davis GL, Czaja AJ, Baggenstoss AH, Taswell HF 1982 Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitis. Mayo Clin. Proc. 57: 303-309.

• De la Concha EG, Garcia-Rodriguez MC, Zabay JM, Laso MT, Alonso F, Bootello A, Fontan G 1982 Functional assessment of T and B lymphocytes in patients with selective IgM deficiency. Clin. Exp. Immunol. 49: 670-676. *

• Delacroix DL, Reynaert M, Pauwels S, Geubel AP, Vaerman JP 1982 High serum levels of secretory IgA in liver disease: possible liver origin of the circulating secretory component. Dig. Dis. Sci. 27: 333-340.

• DeMark BR, Everson GT, Klein PD, Showalter RB, Kern F Jr 1982 A method for the accurate measurement of isotope ratios of chenodeoxycholic and cholic acids in serum. J. Lipid Res. 23: 204-210. *

• Di Bisceglie AM, Segal I 1982 Terminology of sclerosing cholangitis. J. Clin. Gastroenterol. 4: 480.

• Dienstag JL, Savarese AM, Cohen RB, Bhan AK 1982 Circulating immune complexes in primary biliary cirrhosis: interactions with lymphoid cells. Clin. Exp. Immunol. 50: 7-16. *

• Dolle W 1982 Liver damage caused by drugs. Dtsch. Z. Verdau. Stoffwechselkr. 42: 237-244.

• Doyle FH, Pennock JM, Banks LM, McDonnell MJ, Bydder GM, Steiner RE, Young IR, Clarke GJ, Pasmore T, Gilderdale DJ 1982 Nuclear magnetic resonance imaging of the liver: initial experience. AJR Am. J. Roentgenol. 138: 193-200. *

• Drozd TN 1982 Differential morphological diagnosis of chronic liver diseases based on the results of puncture biopsy. Arkh. Patol. 44: 73-78.

• Eason RJ, Croxson MS, Perry MC, Somerfield SD 1982 Addison's disease, adrenal autoantibodies and computerised adrenal tomography. N. Z. Med. J. 95: 569-573.

• Eggink HF, Houthoff HJ, Huitema S, Gips CH, Poppema S 1982 Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. Clin. Exp. Immunol. 50: 17-24. *

• Emerit J, Congy F, Loeper J 1982 Recent data on the epidemiology and etiology of Crohn's disease. Nouv. Presse. Med. 11: 3195-3200.

• Epstein O, Chapman RW, Lake-Bakaar G, Foo AY, Rosalki SB, Sherlock S 1982 The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology 83: 1177-1182.

• Epstein O, Kato Y, Dick R, Sherlock S 1982 Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am. J. Clin. Nutr. 36: 426-430. *

• Everson GT, McKinley C, Lawson M, Johnson M, Kern F Jr 1982 Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology 82: 711-719.

• Falco D, Daniels RA, Conklin R 1982 An unusual case of hypersensitivity vasculitis probably due to allopurinol. J. Med. Soc. N. J. 79: 409-412.

• Finegold MJ, Carpenter RJ 1982 Obliterative cholangitis due to cytomegalovirus: a possible precursor of paucity of intrahepatic bile ducts. Hum. Pathol. 13: 662-665.

• Fondacaro JD, Heubi JE, Kellogg FW 1982 Intestinal bile acid malabsorption in cystic fibrosis: a primary mucosal cell defect. Pediatr. Res. 16: 494-498.

• Freese D, Latimer JS, Gilberstadt S, Kane W, Sharp HL 1982 Sclerosing cholangitis associated with inflammatory bowel disease. Clin. Pediatr. (Phila.) 21: 11-16.

• Gero L, Koranyi L, Szalay F, Buki B, Tamas G Jr 1982 Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block. Acta Diabetol. Lat. 19: 55-64.

• Ghosn PB, Rabbat AG, Trudel J, D'Amico P, Lecours R, Trudel J 1982 Celiac compression syndrome. Can. J. Surg. 25: 377-379.

• Gibson T, Rodgers V, Potter C, Simmonds HA 1982 Allopurinol treatment and its effect on renal function in gout: a controlled study. Ann. Rheum. Dis. 41: 59-65. *

• Gill RA, Onstad GR, Cardamone JM, Maneval DC, Sumner HW 1982 Hepatic veno-occlusive disease caused by 6-thioguanine. Ann. Intern. Med. 96: 58-60.

• Gillberg R, Dotevall G, Ahren C 1982 Chronic inflammatory bowel disease in patients with coeliac disease. Scand. J. Gastroenterol. 17: 491-496.

• Gilmore IT, Marigold JH, Thompson RP 1982 Half-life time or clearance of indocyanine green in patients with liver disease. Hepatogastroenterology 29: 55-57.

• Golematis B, Giannopoulos A, Papachristou DN, Dreiling DA 1982 Sclerosing cholangitis of the bifurcation of the common hepatic duct. Mt. Sinai J. Med. 49: 38-40.

• Graham-Brown RA, Sarkany I, Sherlock S 1982 Lichen planus and primary biliary cirrhosis. Br. J. Dermatol. 106: 699-703.

• Greenberg DA, Hodge SE, Rotter JI 1982 Evidence for recessive and against dominant inheritance at the HLA-"linked" locus in coeliac disease. Am. J. Hum. Genet. 34: 263-277. *

• Greenberg DA, Lange KL 1982 A maximum likelihood test of the two locus model for coeliac disease. Am. J. Med. Genet. 12: 75-82.

• Gupta RC, Dickson ER, McDuffie FC, Baggenstoss AH 1982 Immune complexes in primary biliary cirrhosis. Higher prevalence of circulating immune complexes in patients with associated autoimmune features. Am. J. Med. 73: 192-198.

• Gurian LE, Keeffe EB 1982 Pancreatic insufficiency associated with ulcerative colitis and pericholangitis. Gastroenterology 82: 581-585.

• Handelsman B, Bonorris G, Marks JW, Schoenfield LJ 1982 Enrichment of bile with tauroursodeoxycholic acid and biliary cholesterol saturation in hamsters. Am. J. Physiol. 243: G424-G427.

• Heikkinen J, Maentausta O, Ylostalo P, Janne O 1982 Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. Eur. J. Obstet. Gynecol. Reprod. Biol. 14: 153-162.

• Hendricks AA, Hutcheon DF, Maddrey WC, Farmer ER, Provost TT 1982 Cutaneous immunoglobulin deposition in primary biliary cirrhosis. Arch. Dermatol. 118: 634-637.

• Herlong HF, Recker RR, Maddrey WC 1982 Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology 83: 103-108.

• Hill DL, Grubbs CJ 1982 Retinoids as chemopreventive and anticancer agents intact animals (review). Anticancer Res. 2: 111-124.

• Hishon S, Tobin G, Ciclitira PJ 1982 A clinical trial of levamisole in primary biliary cirrhosis. Postgrad. Med. J. 58: 701-703.

• Hislop WS, Hopwood D, Bouchier IA 1982 Primary biliary cirrhosis in elderly females. Age Ageing 11: 153-159.

• Hislop WS, Masterton N, Bouchier IA, Hopwood D 1982 Cirrhosis and primary liver cell carcinoma in Tayside: a five year study. Scott. Med. J. 27: 29-36.

• Hodes JE, Grosfeld JL, Weber TR, Schreiner RL, Fitzgerald JF, Mirkin LD 1982 Hepatic failure in infants on total parenteral nutrition (TPN): clinical and histopathologic observations. J. Pediatr. Surg. 17: 463-468.

• Hoek FJ, Grijm R, Sanders GT, Tytgat GN, Wilmink JM 1982 Removal of bile acids from the blood by hemodialysis with a polyacrylonitril membrane: treatment of pruritus of cholestatic disease. Digestion 23: 135-140.

• Holda ME, Ryan JR 1982 Hepatobiliary rickets. J. Pediatr. Orthop. 2: 285-287.

• Holdstock G, Chastenay BF, Krawitt EL 1982 Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity. Gastroenterology 82: 206-212.

• Honeybourne D, Dyer PA, Mohr PD 1982 Familial myasthenia gravis. J. Neurol. Neurosurg. Psychiatry 45: 854-856.

• Humbert W, Aprahamian M, Stock C, Grenier JF 1982 Copper accumulation in primary biliary cirrhosis. An electron and X-ray microanalytical study. Histochemistry 74: 85-93.

• Husby G, Blomhoff JP, Elgjo K, Williams RC Jr 1982 Immunohistochemical characterization of hepatic tissue lymphocyte subpopulations in liver disease. Scand. J. Gastroenterol. 17: 855-860.

• Iwamura K 1982 Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones. Tokai. J. Exp. Clin. Med. 7: 671-683.

• Janossy G, Montano L, Selby WS, Duke O, Panayi G, Lampert I, Thomas JA, Granger S, Bofill M, Tidman N, Thomas HC, Goldstein G 1982 T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host disease. J. Clin. Immunol. 2: 42S-56S.

• Jernigan JD, Harbison RD 1982 Role of biotransformation in the potentiation of halocarbon hepatotoxicity by 2,5-hexanedione. J. Toxicol. Environ. Health 9: 761-781.

• Jorge A, Fay O, Palazzi J, Sanchez D, Tanno H, Diaz M 1982 Determination of cholic and sulfolithocholic acids in various hepatopathies. Acta Gastroenterol. Latinoam. 12: 143-147.

• Kanazawa Y, Koizumi M, Hirakawa H, Endo K, Yoshida S, Miyakawa T, Konno Y, Goto Y, Goto J, Nambara T 1982 The effect of ursodeoxycholic acid on biliary bile acid composition in patients with cholesterol gallstone. Tohoku. J. Exp. Med. 136: 235-249. *

• Karr RW, Hahn Y, Schwartz BD 1982 Structural identity of human histocompatibility leukocyte antigen-B27 molecules from patients with ankylosing spondylitis and normal individuals. J. Clin. Invest. 69: 443-450.

• Kato Y, Epstein O, Dick R, Sherlock S 1982 Radiological patterns of cortical bone modelling in women with chronic liver disease. Clin. Radiol. 33: 313-317.

• Kato Y, Kumagai M, Kobayashi K, Hattori N, Sasazuki T 1982 Histocompatibility antigens in primary biliary cirrhosis. Am. J. Gastroenterol. 77: 312-313.

• Kennedy HJ, Callender ST, Truelove SC, Warner GT 1982 Haematological aspects of life with an ileostomy. Br. J. Haematol. 52: 445-454.

• Kern F Jr, Everson GT, DeMark B, McKinley C, Showalter R, Braverman DZ, Szczepanik-Van Leeuwen P, Klein PD 1982 Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids. J. Lab. Clin. Med. 99: 798-805.

• Kesaniemi YA, Salaspuro MP, Vuoristo M, Miettinen TA 1982 Biliary lipid secretion in chronic cholestatic liver disease. Gut 23: 931-938. *

• Kivilaakso E 1982 Antacids and bile salts. Scand. J. Gastroenterol. Suppl. 75: 16-19.

• Kloppel G, Kirchhof M, Berg PA 1982 Natural course of primary biliary cirrhosis. I. A morphological, clinical and serological analysis of 103 cases. Liver 2: 141-151.

• Kobyliansky E, Micle S, Goldschmidt-Nathan M, Arensburg B, Nathan H 1982 Jewish populations of the world: genetic likeness and differences. Ann. Hum. Biol. 9: 1-34.

• Krell H, Hoke H, Pfaff E 1982 Development of intrahepatic cholestasis by alpha-naphthylisothiocyanate in rats. Gastroenterology 82: 507-514.

• Kurtz W, Leuschner U, Hellstern A, Janka P 1982 Sex differences in rat liver bile acids. Hepatogastroenterology 29: 227-231.

• Lazarow PB, Shio H, Leroy-Houyet MA 1982 Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat. J. Lipid Res. 23: 317-326. *

• Lee WM, Silva F, Price JB Jr 1982 Gastrin-secreting tumor of the duodenum (G-cell apudoma) associated with secondary biliary cirrhosis. Cancer 49: 2596-2601.

• Lefkowitch JH 1982 Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and "cholangitis lenta". Hum. Pathol. 13: 19-24.

• Lefkowitch JH 1982 Primary sclerosing cholangitis. Arch. Intern. Med. 142: 1157-1160.

• Leistner K, Wessel G 1982 Epidemiologic aspects of seronegative spondylarthritis. Z. Gesamte. Inn. Med. 37: 627-632.

• Leuschner U, Strohm WD, Classen M 1982 Clinical features of inflammatory bowel disease. Acta Med. Austriaca. 9: 9-17.

• Liehr H 1982 Endotoxins and the pathogenesis of hepatic and gastrointestinal diseases. Ergeb. Inn. Med. Kinderheilkd. 48: 117-193.

• Lindenborn-Fotinos J, Sayers TJ, Berg PA 1982 Mitochondrial antibodies in primary biliary cirrhosis. VI. Association of the complement fixing antigen with a component of the mitochondrial F1-ATPase complex. Clin. Exp. Immunol. 50: 267-274. *

• Lindgren S, Eriksson S 1982 IgM in primary biliary cirrhosis. Physicochemical and complement activating properties. J. Lab. Clin. Med. 99: 636-645.

• Longstreth GF, Green R 1982 Folate levels in inflammatory bowel disease. N. Engl. J. Med. 306: 1488.

• MacDonald JR, Gandolfi AJ, Sipes IG 1982 Covalent binding of 14C-1,1,2-trichloroethane to hepatic proteins following acetone pretreatment. Drug Chem. Toxicol. 5: 233-247.

• MacDonald JR, Gandolfi AJ, Sipes IG 1982 Acetone potentiation of 1,1,2-trichloroethane hepatotoxicity. Toxicol. Lett. 13: 57-69.

• Maier K, Fischer C, Klotz U, Heinkel K 1982 5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl.). Dtsch. Med. Wochenschr. 107: 1131-1134.

• Manifold IH, Bishop FM, Cloke P, Triger DR, Underwood JC 1982 Lysozyme in chronic liver disease: a biochemical and histological study. J. Clin. Pathol. 35: 815-819. *

• Manns M, Meyer zum Buschenfelde KH 1982 A mitochondrial antigen-antibody system in cholestatic liver disease detected by radioimmunoassay. Hepatology 2: 1-7.

• Marigold JH, Bull HJ, Gilmore IT, Coltart DJ, Thompson RP 1982 Direct measurement of hepatic extraction of chenodeoxycholic acid and ursodeoxycholic acid in man. Clin. Sci. (Lond.) 63: 197-203.

• Matloff DS, Alpert E, Resnick RH, Kaplan MM 1982 A prospective trial of D-penicillamine in primary biliary cirrhosis. N. Engl. J. Med. 306: 319-326.

• Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ 1982 Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology 83: 97-102.

• McLean GK, Ring EJ, Freiman DB 1982 Therapeutic alternatives in the treatment of intrahepatic biliary obstruction. Radiology 145: 289-295. *

• Meek FL 1982 A direct binding assay for mitochondrial autoantibodies. J. Immunol. Methods 51: 109-118.

• Meredith TJ, Williams GV, Maton PN, Murphy GM, Saxton HM, Dowling RH 1982 Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones. Gut 23: 382-389. *

• Meryhew NL, Marsden K, Runquist OA 1982 The quantitative relationship between clearance rate constants and number of C1-fixing sites. J. Immunol. 129: 1147-1152.

• Mills PR, Boyle P, Quigley EM, Birnie GG, Jarrett F, Watkinson G, MacSween RN 1982 Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies? J. Clin. Pathol. 35: 541-543. *

• Minami Y, Seki K, Nishikawa M, Kawata S, Miyoshi S, Imai Y, Tarui S, Kakiuchi Y, Shinji Y, Kiyonaga G 1982 Laparoscopic findings of the liver in the diagnosis of primary biliary cirrhosis: "reddish patch", a laparoscopic feature in the asymptomatic stage. Endoscopy 14: 203-208.

• Miyai K, Javitt NB, Gochman N, Jones HM, Baker D 1982 Hepatotoxicity of bile acids in rabbits: ursodeoxycholic acid is less toxic than chenodeoxycholic acid. Lab. Invest. 46: 428-437.

• Molden D, Abraham JL 1982 Pulmonary hypertension. Its association with hepatic cirrhosis and iron accumulation. Arch. Pathol. Lab. Med. 106: 328-331.

• Moller P, Vinje O, Berg K 1982 HLA antigens, psoriasis and acute anterior uveitis in Bechterew's syndrome (ankylosing spondylitis). Clin. Genet. 21: 215-221.

• Morgan MY, Marshall AW, Milsom JP, Sherlock S 1982 Plasma amino-acid patterns in liver disease. Gut 23: 362-370. *

• Moss DW 1982 Alkaline phosphatase isoenzymes. Clin. Chem. 28: 2007-2016.

• Mueller PR, vanSonnenberg E, Simeone JF 1982 Fine-needle transhepatic cholangiography. Indications and usefulness. Ann. Intern. Med. 97: 567-572.

• Munoz LE, De Villiers D, Markham D, Whaley K, Thomas HC 1982 Complement activation in chronic liver disease. Clin. Exp. Immunol. 47: 548-554. *

• Muting D, Fischer R, Kalk JF, Kruck P 1982 Chronic destructive non-suppurating cholangitis. Fortschr. Med. 100: 1179-1187.

• Nakanuma Y, Kono N, Ohta G, Kato Y, Kobayashi K 1982 Ultrastructural changes of bile duct epithelium in primary biliary cirrhosis in relation to progression of bile duct loss. Virchows Arch. A. Pathol. Anat. Histopathol. 398: 149-161.

• Nakanuma Y, Ohta G, Kobayashi K, Kato Y 1982 Histological and histometric examination of the intrahepatic portal vein branches in primary biliary cirrhosis without regenerative nodules. Am. J. Gastroenterol. 77: 405-413.

• Nelson RA 1982 Use and misuse of vitamins in the elderly. Geriatrics 37: 138-140, 144.

• Neuberger J, Portmann B, Macdougall BR, Calne RY, Williams R 1982 Recurrence of primary biliary cirrhosis after liver transplantation. N. Engl. J. Med. 306: 1-4.

• Nguyen GK 1982 Primary extranodal non-Hodgkin's lymphoma of the extrahepatic bile ducts. Report of a case. Cancer 50: 2218-2222.

• Nishida T, Miwa H, Yamamoto M, Koga T, Yao T 1982 Bile acid absorption kinetics in Crohn's disease on elemental diet after oral administration of a stable-isotope tracer with chenodeoxycholic-11, 12-d2 acid. Gut 23: 751-757. *

• Novikova AV, Shcherbakov IT, Ol'shanskii IaO, Iurkov MM, Levitan MKh 1982 Features of inflammation of the mucosa of the large intestine in nonspecific ulcerative colitis and Crohn's disease. Arkh. Patol. 44: 31-39.

• Oen K, Petty RE, Schroeder ML 1982 Immunoglobulin A deficiency: genetic studies. Tissue Antigens 19: 174-182.

• Peters M, Tinberg HM, Govindarajan S 1982 Immunocytochemical identity of hepatocellular hyalin in alcoholic and non-alcoholic liver diseases. Liver 2: 361-368.

• Pitt HA, Thompson HH, Tompkins RK, Longmire WP Jr 1982 Primary sclerosing cholangitis: results of an aggressive surgical approach. Ann. Surg. 196: 259-268. *

• Podda M, Zuin M, Carulli N, Ponz de Leon M, Dioguardi ML 1982 Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses. J. Int. Med. Res. 10: 59-63.

• Pond SM 1982 Effects on the liver of chemicals encountered in the workplace. West J. Med. 137: 506-514. *

• Popov MS, Rutkovskii OV 1982 Primary biliary liver cirrhosis with a granulomatous reaction. Arkh. Patol. 44: 60-63.

• Radzevich IM 1982 Two forms of alkaline phosphatase in blood serum in liver diseases. Ukr. Biokhim. Zh. 54: 525-529.

• Rajagopalan N, Lindenbaum S 1982 The binding of Ca2+ to taurine and glycine-conjugated bile salt micelles. Biochim. Biophys. Acta 711: 66-74.

• Ramarli D, Canonica GW, Melioli G, Biagioni P, Nieri S, Casini A, Surrenti C 1982 Abnormalities of immunocompetent cells in primary biliary cirrhosis. Scand. J. Immunol. 16: 201-207.

• Rammohan KW, McFarland HF, McFarlin DE 1982 Subacute sclerosing panencephalitis after passive immunization and natural measles infection: role of antibody in persistence of measles virus. Neurology 32: 390-394.

• Ramond MJ, Nouel O, Degott C, Lebrec D, Benhamou JP 1982 Allopurinol-induced hepatitis. Report of a case and review of the literature. Gastroenterol. Clin. Biol. 6: 138-142.

• Rhodes JM, Potter BJ, Brown DJ, Jewell DP 1982 Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis. Gastroenterology 82: 1327-1334.

• Ritland S, Skrede S, Johansen O 1982 A long-term follow-up study of the hepatic copper and serum ceruloplasmin concentrations in patients with chronic liver disease. Scand. J. Gastroenterol. 17: 545-551.

• Roda E, Bazzoli F, Labate AM, Mazzella G, Roda A, Sama C, Festi D, Aldini R, Taroni F, Barbara L 1982 Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study. Hepatology 2: 804-810.

• Rouffet F, Fingerhut A, Desoutter P, Blanc P 1982 Primary sclerosing cholangitis associated with ulcerohemorrhagic rectocolitis. Review of the literature apropos of a case disclosed by a rare manifestation: biliary peritonitis. J. Chir. (Paris) 119: 577-582.

• Roy CC, Weber AM, Morin CL, Lepage G, Brisson G, Yousef I, Lasalle R 1982 Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts. J. Pediatr. Gastroenterol. Nutr. 1: 469-478.

• Ruppin DC, Frydman MI, Lunzer MR 1982 Value of serum gamma-glutamyltransferase activity in the diagnosis of hepatobiliary disease. Med. J. Aust. 1: 421-424.

• Rutgeerts P, Ghoos Y, Vantrappen G 1982 Kinetics of primary bile acids in patients with non-operated Crohn's disease. Eur. J. Clin. Invest. 12: 135-143.

• Saito K, Matsumoto S, Yokoyama T, Okaniwa M, Kamoshita S 1982 Pathology of chronic vitamin E deficiency in fatal familial intrahepatic cholestasis (Byler disease). Virchows Arch. A. Pathol. Anat. Histol. 396: 319-330.

• Sakurami T, Ueno Y, Iwaki Y, Park MS, Terasaki PI, Saji H 1982 HLA-DR specificities among Japanese with several autoimmune diseases. Tissue Antigens 19: 129-133.

• Samuelson K, Aly A, Johansson C, Norman A 1982 Serum and urinary bile acids in patients with primary biliary cirrhosis. Scand. J. Gastroenterol. 17: 121-128.

• Schlaeger R, Haux P, Kattermann R 1982 Studies on the mechanism of the increase in serum alkaline phosphatase activity in cholestasis: significance of the hepatic bile acid concentration for the leakage of alkaline phosphatase from rat liver. Enzyme 28: 3-13.

• Schrumpf E, Fausa O, Forre O, Dobloug JH, Ritland S, Thorsby E 1982 HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand. J. Gastroenterol. 17: 187-191.

• Schrumpf E, Fausa O, Kolmannskog F, Elgjo K, Ritland S, Gjone E 1982 Sclerosing cholangitis in ulcerative colitis. A follow-up study. Scand. J. Gastroenterol. 17: 33-39.

• Schuurman HJ, Vogten AJ, Schalm SW, Fevery J 1982 Clinical evaluation of the liver cell membrane autoantibody assay. Digestion 23: 184-193.

• Selinger MJ, Matloff DS, Kaplan MM 1982 gamma-Glutamyl transpeptidase activity in liver disease: serum elevation is independent of hepatic GGTP activity. Clin. Chim. Acta 125: 283-290.

• Senati E, Marconi F, Tomassini N, Stipa F 1982 Papillomatosis of the bile ducts: a clinical case. Chir. Ital. 34: 432-437.

• Sepersky R, Callow A, Kanel G, Kaplan M 1982 Portasystemic shunts in primary biliary cirrhosis: survival is the same as in patients with Laennec's cirrhosis and postnecrotic cirrhosis. Dig. Dis. Sci. 27: 507-512.

• Sherlock S 1982 Patterns of hepatocyte injury in man. Lancet 1: 782-786.

• Sherlock S 1982 Primary biliary cirrhosis: critical evaluation and treatment policies. Scand. J. Gastroenterol. Suppl. 77: 63-74.

• Shimomura H 1982 Studies on anti-LP-1 and anti-Tamm-Horsfall glycoprotein in chronic liver disease using ADCC assay against antigen-coated target cells. Acta Med. Okayama 36: 361-370.

• Shore A, Ansell BM 1982 Juvenile psoriatic arthritis - an analysis of 60 cases. J. Pediatr. 100: 529-535.

• Simko V, Kelley RE, Dincsoy HP, Gimmon Z, Willmann K 1982 Exercise in rats with liver injury induced by carbon tetrachloride or bile duct obstruction. Blood cholic acid and liver histology. Res. Exp. Med. (Berl.) 181: 135-145.

• Simon FR, Reichen J 1982 Bile secretory failure: recent concepts of the pathogenesis of intrahepatic cholestasis. Prog. Liver Dis. 7: 195-206.

• Skrede S, Solberg HE, Ritland S, Blomhoff JP, Schrumpf E, Elgjo K, Gjone E 1982 Diagnostic and prognostic value of laboratory tests assessed in a follow-up study of 200 patients with liver disease. Clin. Chem. 28: 1177-1181.

• Sloan RW 1982 Hyperuricemia and gout. J. Fam. Pract. 14: 923-926, 930-9311, 934.

• Smevik B, Ritland S, Nilsen T, Johansen O 1982 Liver attenuation values at computed tomography related to liver copper content. Scand. J. Gastroenterol. 17: 461-463.

• Smolen JS, Gangl A, Polterauer P, Menzel EJ, Mayr WR 1982 HLA antigens in inflammatory bowel disease. Gastroenterology 82: 34-38.

• Spivak W, Grand RJ, Eraklis A 1982 A case of primary sclerosing cholangitis in childhood. Gastroenterology 82: 129-132.

• Spooner RJ, Smith DH, Bedford D, Beck PR 1982 Serum gamma-glutamyltransferase and alkaline phosphatase in rheumatoid arthritis. J. Clin. Pathol. 35: 638-641. *

• Summers RW, Harker L 1982 Ulcerative colitis and sensorineural hearing loss: is there a relationship? J. Clin. Gastroenterol. 4: 251-252.

• Sutherland JD, Macdonald IA, Forrest TP 1982 The enzymic and chemical synthesis of ursodeoxycholic and chenodeoxycholic acid from cholic acid. Prep. Biochem. 12: 307-321.

• Taal BG, Schalm SW, de Bruyn AM, Kornman-vd Bosch HJ 1982 Monomeric (7S) IgM in primary biliary cirrhosis. Scand. J. Gastroenterol. 17: 173-175.

• Takikawa H, Otsuka H, Beppu T, Seyama Y, Yamakawa T 1982 Quantitative determination of bile acid glucuronides in serum by mass fragmentography. J. Biochem. (Tokyo) 92: 985-998.

• Tanggo Y, Fujiyama S, Kin F, Tashiro A, Shiraoku H, Akahoshi M, Sato Y, Hashiguchi O, Sagara K 1982 Clinical usefulness of serum cholylglycine determination in various liver diseases. Gastroenterol. Jpn. 17: 447-452.

• Thistle JL, LaRusso NF, Hofmann AF, Turcotte J, Carlson GL, Ott BJ 1982 Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study. Dig. Dis. Sci. 27: 161-168.

• Thomas HC, Brown D, Labrooy J, Epstein O 1982 T cell subsets in autoimmune and HBV-induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: a review of the abnormalities and the effects of treatment. J. Clin. Immunol. 2: 57S-60S.

• Thompson HH, Pitt HA, Tompkins RK, Longmire WP Jr 1982 Primary sclerosing cholangitis: a heterogenous disease. Ann. Surg. 196: 127-136. *

• Tint GS, Salen G, Colalillo A, Graber D, Verga D, Speck J, Shefer S 1982 Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones. Ann. Intern. Med. 97: 351-356.

• Tison V, Callea F, Morisi C, Mancini AM, Desmet VJ 1982 Spontaneous "primary biliary cirrhosis" in rabbits. Liver 2: 152-161.

• Tobe K 1982 Electron microscopy of liver lesions in primary biliary cirrhosis. II. A bile duct with chronic non-suppurative destructive cholangitis. Acta Pathol. Jpn. 32: 345-357.

• Tobe K 1982 Electron microscopy of liver lesions in primary biliary cirrhosis. I. Intrahepatic bile duct oncocytes. Acta Pathol. Jpn. 32: 57-70.

• Tonami N, Nakajima K, Hisada K, Tanaka N, Kobayashi K 1982 A noninvasive method for evaluating portal circulation by administration of Ti-201 per rectum. J. Nucl. Med. 23: 965-972.

• Trautmann F, Arnold W, Manns M, Stoltenburg-Didinger G, Meyer zum Buschenfelde KH 1982 Antimitochondrial antibodies against the M2-antigen with immune vasculitis and discoid lupus erythematosus without proof of liver disease. Z. Gastroenterol. 20: 659-666.

• Triger DR, Charlton CA, Ward AM 1982 What does the antimitochondrial antibody mean? Gut 23: 814-818. *

• Uibo RM, Helin HJ, Krohn KJ 1982 Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits. Clin. Exp. Immunol. 48: 505-512. *

• Ulfarsson J, Gudmundsson S, Birgisdottir B, Kjeld JM, Jensson O 1982 Selective serum IgA deficiency in Icelanders. Frequency, family studies and Ig levels. Acta Med. Scand. 211: 481-487.

• Valla D, Delage Y, Habibi B, Sonsino E, Darnis F, Bodin F 1982 Ulcerative colitis and primary immunoglobulin deficiency. Gastroenterol. Clin. Biol. 6: 879-885.

• van der Hoek EW, Yap SH, Lamers CB, van Tongeren JH, Strijk S, Boetes C, van Haelst UJ 1982 Sclerosing cholangitis, a variable disease picture. Ned. Tijdschr. Geneeskd. 126: 1724-1729.

• van Hees PA, van Tongeren JH 1982 Compliance to therapy in patients on a maintenance dose of sulfasalazine. J. Clin. Gastroenterol. 4: 333-336.

• Vasey FB, Espinoza LR, Bocanegra TS, Germain BF 1982 The major histocompatibility complex. Ann. Clin. Lab. Sci. 12: 16-22.

• Vender RJ, Spiro HM 1982 Inflammatory bowel disease and pregnancy. J. Clin. Gastroenterol. 4: 231-249.

• Vilstrup H, Bucher D, Krog B, Damgard SE 1982 Elimination of infused amino acids from plasma of control subjects and of patients with cirrhosis of the liver. Eur. J. Clin. Invest. 12: 197-202.

• Volmer J 1982 The effectivity of immunosuppressive therapy on chronic aggressive (active) hepatitis and on chronic nonsuppurative destructive cholangitis (PBC). Morphometric investigations on the portal tracts of the liver. Liver 2: 82-94.

• Whelan G, Peters M, Desmond PV, Bhathal PS 1982 Alcohol unrelated hepato-biliary disorders in the alcoholic: the role of liver biopsy in determining the aetiology of liver disease. Aust. N. Z. J. Med. 12: 34-38.

• Witzleben CL 1982 Bile duct paucity ("intrahepatic atresia"). Perspect. Pediatr. Pathol. 7: 185-201.

• Wurm K 1982 Current status of clinical and scientific sarcoidosis research 100 years later. Fortschr. Med. 100: 1560-1563.

• Yamaguchi Y, Yamaguchi K, Babb JL, Gans H 1982 In vivo quantitation of the rat liver's ability to eliminate endotoxin from portal vein blood. J. Reticuloendothel. Soc. 32: 409-422.

• Yates VM, Watkinson G, Kelman A 1982 Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis. Br. J. Dermatol. 106: 323-330.

• Zile MH, Inhorn RC, DeLuca HF 1982 Metabolites of all-trans-retinoic acid in bile: identification of all-trans- and 13-cis-retinoyl glucuronides. J. Biol. Chem. 257: 3537-3543. *

• Zouboulis-Vafiadis I, Dumont M, Erlinger S 1982 Conjugation is rate limiting in hepatic transport of ursodeoxycholate in the rat. Am. J. Physiol. 243: G208-G213.

Number of references = 202

www psc-literature.org